November Heats Up for Biotech; Bio-Defense Cools

Invitrogen Sells $500M In Convertible Notes

Marion Webb
Staff Writer

Investments in biotechnology companies expanded in November despite the deep economic woes, according to a recent report by Burrill & Co...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $99